This event is supported by industry sponsorship, including pharmaceutical companies. Sponsors have had no input into the agenda or speaker selection except for sponsored sessions, which are clearly labelled on the programme.

See all sponsors and exhibitors at this event

British Society of Haematology and Children's Cancer and Leukaemia Group (CCLG)

Time slot
Tuesday 12 May 2026 - 13:45-16:00
Room
Hall 8B
Session type
Specialty group session

Programme 

Update of the management of sickle cell disease. 

Diagnosing cancer in children and young people. Dr Shaarna Shanmugavadivel, CCLG Early Diagnosis Fellow, University of Nottingham.

Abstracts

  • Awareness regarding thalassemia and knowledge of the risks of repeated transfusions among caregivers of transfusion-dependent β-thalassemia children.
  • Centering young voices: a patient and public involvement and engagement (PPIE) project in paediatric sickle cell services.
  • Standardisation of Secondary Line Management of Paediatric Immune Thrombocytopenia.
  • Evaluating support for the debrief process for paediatric oncology trainee doctors and newly-appointed consultants after child death.
  • Inequities in the provision, delivery and outcomes in paediatric oncology care in the United Kingdom: a scoping review. 

Speakers

  • Dr Mark Velangi - Consultant, Birmingham Children's Hospital
  • Ashley Gamble - CEO, CCLG
  • Dr Shaarna Shanmugavadivel - CCLG Early Diagnosis Fellow, University of Nottingham
Clinical: Sub-specialty